Company Filing History:
Years Active: 2004-2009
Title: Nicolas Inguimbert: Innovator in Medical Chemistry
Introduction
Nicolas Inguimbert is a notable inventor based in Cachan, France. He has made significant contributions to the field of medical chemistry, particularly in the development of compounds aimed at treating arterial hypertension. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
Inguimbert's latest patents include innovative derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates). This invention focuses on compounds that are useful for the treatment and prevention of primary and secondary arterial hypertension. Another significant patent involves amino acid derivatives that serve as NEP, ACE, and ECE inhibitors, showcasing his expertise in creating effective therapeutic agents.
Career Highlights
Throughout his career, Nicolas Inguimbert has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale. His research has contributed to the understanding and treatment of various medical conditions, particularly those related to cardiovascular health.
Collaborations
Inguimbert has collaborated with notable professionals in his field, including Bernard P. Roques and Marie-Claude Fournie-Zaluski. These partnerships have enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Nicolas Inguimbert's work exemplifies the intersection of innovation and healthcare. His patents and collaborations highlight his dedication to improving medical treatments and advancing scientific knowledge.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.